Publicis hooks Microsoft's Razorfish

Share this article:
Publicis will acquire Razorfish, a Microsoft-owned digital and interactive shop, for roughly $530 million, according to joint company statements.

Razorfish will continue to operate under its brand name, and retain its management structure, led by CEO Bob Lord.

David Deal, a Razorfish spokesperson, said the agency is anticipating “business as usual for Razorfish, including our health practice, and we do not foresee sweeping changes otherwise.” Publicis will integrate Razorfish into its newly created VivaKi group, which incorporates digital and media assets such as Digitas and Denuo into a “nerve center,” tasked with global talent development and the creation of “a new approach to strategic scale across platforms, partners and technology,” according to the VivaKi website.

The acquisition follows a partnership between Publicis and Microsoft that was announced in June, allowing several of Publicis's agencies within the VivaKi group—which also includes Starcom MediaVest Group and ZenithOptimedia—to use Microsoft's Admira technology for media planning, buying and measurement.

Admira is slated to launch during the fourth quarter of this year.

Razorfish's clients include Wyeth, Schering-Plough, Johnson & Johnson and others. The agency has hinted at formalizing its healthcare operations in recent months, but has been unable to comment on that development.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?